SHI
SV Health Investors Portfolio holdings
AUM $32.3M
1-Year Return
20.15%
This Quarter Return
+25.23%
1 Year Return
-20.15%
3 Year Return
+90.94%
5 Year Return
+318.05%
10 Year Return
–
AUM
$133M
AUM Growth
-$56M
(-30%)
Cap. Flow
-$72.2M
Cap. Flow
% of AUM
-54.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
RSLS
ReShape Lifesciences Inc. Common Stock
RSLS
|
+$3.26M |
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$72.1M |
| 2 |
ETRM
EnteroMedics Inc.
ETRM
|
+$3.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
X4 Pharmaceuticals
XFOR
$72.1M
| $42.8M | 32.08% |
10,383
| – | – |
|
|
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $34.4M | 25.79% |
1,716,303
| – | – |
|
3
KalVista Pharmaceuticals
KALV
$682M
| $24.5M | 18.34% |
2,579,490
| – | – |
|
|
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
| $12.8M | 9.62% |
580,515
| – | – |
|
5
Ocular Therapeutix
OCUL
$2.16B
| $10.4M | 7.84% |
1,605,207
| – | – |
|
6
Astria Therapeutics
ATXS
$410M
| $5.17M | 3.88% |
47,628
| – | – |
|
|
RSLS
7
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
| $3.26M | 2.45% |
+1,072
| New | +$3.26M |
|
|
ENTL
8
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| – | – |
-2,956,456
| Closed | -$72.1M |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| – | – |
-2,250,958
| Closed | -$3.33M |
|